射血分数保留的心力衰竭中共病-炎症范式的蛋白质组学评估:PROMIS-HFpEF研究结果
在228例HFpEF患者中,采用Olink多重免疫分析定量248种循环蛋白,通过演绎法主成分分析和归纳法加权共表达网络分析总结炎症相关蛋白。炎症介导了共病负担与二尖瓣E速度、E/e'比值、三尖瓣反流速度及TAPSE的关联(介导比例13%-41%,P<0.05),并在独立验证队列中得到验证。
要点
- 炎症蛋白网络在HFpEF中保守存在,可能介导共病负担与不良血流动力学及右室功能异常。
- TNFR1、UPAR、IGFBP7和GDF-15是介导共病负担与超声参数关系的主要个体蛋白。
- 炎症介导了共病负担与E/e'、三尖瓣反流速度、TAPSE等的关联,支持共病-炎症范式。
核心结论
- 炎症相关蛋白在HFpEF中形成跨两个独立队列的保守网络,可能介导共病负担与更差血流动力学及右室功能异常的超声指标之间的关联。
研究设计与样本
- 多中心PROMIS-HFpEF研究纳入228例HFpEF患者,用Olink多重免疫分析定量248种循环蛋白。
- 采用主成分分析总结47种已知炎症蛋白,并用加权共表达网络分析识别过代表炎症通路的蛋白簇。
- 共病负担定义为8种常见HFpEF共病之和,用多变量线性回归和统计中介分析评估炎症的中介作用。
- 在117例HFpEF病例和30例无心力衰竭的共病对照组成的独立队列中进行外部验证。
主要发现
- 共病负担与异常心脏结构/功能及炎症蛋白主成分/簇相关。
- 全身炎症与二尖瓣E速度、E/e'比值、三尖瓣反流速度升高及右室功能变差(TAPSE和右室游离壁应变)相关。
- 炎症介导共病负担与二尖瓣E速度(介导比例19%-35%)、E/e'比值(18%-29%)、三尖瓣反流速度(27%-41%)及TAPSE(13%)的关联(P均<0.05),但不介导右室游离壁应变。
- TNFR1、UPAR、IGFBP7和GDF-15是介导共病负担与超声参数关系的主要个体蛋白。
- 验证队列中HFpEF病例炎症上调,且PROMIS-HFpEF中识别的最显著炎症蛋白簇也存在于验证队列的HFpEF病例(而非对照)中。
临床怎么用
- 炎症蛋白网络可能作为HFpEF共病负担与心脏结构/功能异常之间的中介环节,支持针对炎症通路的进一步研究。
- TNFR1、UPAR、IGFBP7和GDF-15等蛋白可能有助于识别炎症介导的HFpEF亚组,但尚需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A systemic proinflammatory state has been hypothesized to mediate the association between comorbidities and abnormal cardiac structure/function in heart failure with preserved ejection fraction (HFpEF). We conducted a proteomic analysis to investigate this paradigm. METHODS: In 228 patients with HFpEF from the multicenter PROMIS-HFpEF study (Prevalence of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction), 248 unique circulating proteins were quantified by a multiplex immunoassay (Olink) and used to recapitulate systemic inflammation. In a deductive approach, we performed principal component analysis to summarize 47 proteins known a priori to be involved in inflammation. In an inductive approach, we performed unbiased weighted coexpression network analyses of all 248 proteins to identify clusters of proteins that overrepresented inflammatory pathways. We defined comorbidity burden as the sum of 8 common HFpEF comorbidities. We used multivariable linear regression and statistical mediation analyses to determine whether and to what extent inflammation mediates the association of comorbidity burden with abnormal cardiac structure/function in HFpEF. We also externally validated our findings in an independent cohort of 117 HFpEF cases and 30 comorbidity controls without heart failure. RESULTS: Comorbidity burden was associated with abnormal cardiac structure/function and with principal components/clusters of inflammation proteins. Systemic inflammation was also associated with increased mitral E velocity, E/e' ratio, and tricuspid regurgitation velocity; and worse right ventricular function (tricuspid annular plane systolic excursion and right ventricular free wall strain). Inflammation mediated the association between comorbidity burden and mitral E velocity (proportion mediated 19%-35%), E/e' ratio (18%-29%), tricuspid regurgitation velocity (27%-41%), and tricuspid annular plane systolic excursion (13%) (P<0.05 for all), but not right ventricular free wall strain. TNFR1 (tumor necrosis factor receptor 1), UPAR (urokinase plasminogen activator receptor), IGFBP7 (insulin-like growth factor binding protein 7), and GDF-15 (growth differentiation factor-15) were the top individual proteins that mediated the relationship between comorbidity burden and echocardiographic parameters. In the validation cohort, inflammation was upregulated in HFpEF cases versus controls, and the most prominent inflammation protein cluster identified in PROMIS-HFpEF was also present in HFpEF cases (but not controls) in the validation cohort. CONCLUSIONS: Proteins involved in inflammation form a conserved network in HFpEF across 2 independent cohorts and may mediate the association between comorbidity burden and echocardiographic indicators of worse hemodynamics and right ventricular dysfunction. These findings support the comorbidity-inflammation paradigm in HFpEF.
引用
- Sanders-van Wijk S, Tromp J, Beussink-Nelson L, et al. Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction: Results From the PROMIS-HFpEF Study. Circulation. 2020. PMID: 33034202. doi:10.1161/CIRCULATIONAHA.120.045810
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。